Accumulating evidence suggests that regulation of CX3CR1 expression is considerably complex in vivo, as CX3CL1 signaling may be either positively or negatively regulated in distinct contexts, such as LPS challenge, experimental autoimmune encephalomyelitis (EAE), multiple sclerosis, and HIV infection [71]. The gene discussed is CX3CR1; the disease is HIV infectious disease.